Murli Krishna Pharma (MKP) is an EU-GMP approved manufacturer of formulations, with demonstrated capability in development of novel drug delivery system (NDDS) products.

With a wide base of customers in several RoW markets, MKP has established itself as a player of repute in the manufacture of complex pellets.

The Company has an impressive product basket in therapy areas such as anti-ulcers, anti- obesity, urology, immunosuppressants, and antidepressants and is building a pipeline of complex products in oncology, ophthalmology and pulmonology.